Back to Search
DIANA LAKE, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1346211380IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
126566(NY)
Education
CHICAGO COLLEGE OF MEDICINE AND SURGERY
Class of 1972
Research & Publications (20)
A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma.
PMID 18751888·Breast Cancer Res Treat·2009
3-trial
Deep anterior lamellar keratoplasty over penetrating keratoplasty for host rim thinning and ectasia.
PMID 19421052·Cornea·2009
8-other
Femoral vascular complications following catheter ablation of atrial fibrillation.
PMID 19387807·J Interv Card Electrophysiol·2009
2-rct
Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines.
PMID 19615748·Mol Immunol·2009
8-other
Endotoxin depresses heart rate variability in mice: cytokine and steroid effects.
PMID 19657103·Am J Physiol Regul Integr Comp Physiol·2009
7-preclinical
Heart rate characteristics and neurodevelopmental outcome in very low birth weight infants.
PMID 19554011·J Perinatol·2009
8-other
The impact of sharing results of a randomized breast cancer clinical trial with study participants.
PMID 18543100·Breast Cancer Res Treat·2009
3-trial
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.
PMID 18509177·J Clin Oncol·2008
8-other
Analysis of in vivo left atrial appendage morphology in patients with atrial fibrillation: a direct comparison of transesophageal echocardiography, planar cardiac CT, and segmented three-dimensional cardiac CT.
PMID 18686024·J Interv Card Electrophysiol·2008
4-observational
Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible.
PMID 18952555·Clin Breast Cancer·2008
3-trial
Endothelial keratoplasty: case selection in the learning curve.
PMID 19034123·Cornea·2008
4-observational
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.
PMID 18375893·J Clin Oncol·2008
3-trial
Variation in cytotoxic T-lymphocyte responses to peptides derived from tyrosinase-related protein-2.
PMID 18295672·Hum Immunol·2008
8-other
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer.
PMID 18323546·J Clin Oncol·2008
3-trial
Deep corneal calcification associated with preservative-free eyedrops and persistent epithelial defects.
PMID 18362655·Cornea·2008
5-case
Management of angle-supported intraocular lens and iridectomy in Descemet-stripping endothelial keratoplasty.
PMID 18216581·Cornea·2008
8-other
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.
PMID 19047117·Clin Cancer Res·2008
3-trial
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer.
PMID 17952589·Breast Cancer Res Treat·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1346211380
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 54
- Publications
- 20
Are you this provider?
Claim Your Profile